Truist Securities Maintains Hold on Teladoc Health, Lowers Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Teladoc Health (NYSE:TDOC) but has lowered the price target from $15 to $10.
August 02, 2024 | 1:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained a Hold rating on Teladoc Health but has lowered the price target from $15 to $10, indicating a more cautious outlook.
The lowered price target from $15 to $10 by Truist Securities suggests a more cautious outlook on Teladoc Health's future performance, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100